Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Wilson

Showing results (61-70 of 424) with videos related to

Pageof 43
Sort By:
Clinical Chemistry|March 2, 2012
A message from the laboratory community to the National Cholesterol Education Program Adult Treatment Panel IVHubert W Vesper, Peter W F Wilson, Nader Rifai
The Australian and New Zealand Journal of Surgery|February 1, 1975
Pancreatic cyst complicated by major arterial erosion and gastrointestinal haemorrhageW F Wilson, R C Wilkie, M R Ewing
Circulation|June 11, 2008
Beyond established and novel risk factors: lifestyle risk factors for cardiovascular diseaseDariush Mozaffarian, Peter W F Wilson, William B Kannel
Circulation|June 16, 2004
Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?Paul M Ridker, Peter W F Wilson, Scott M Grundy
Metabolic Syndrome and Related Disorders|March 29, 2008
Cardiovascular risk and the metabolic syndromeMartin K Rutter, James B Meigs, Peter W F Wilson
Circulation|July 1, 1997
Intermittent claudication. A risk profile from The Framingham Heart StudyJ M Murabito, R B D'Agostino, H Silbershatz, et al.
International Journal of Obesity (2005)|December 15, 2004
Coronary heart disease risk in men and the epidemic of overweight and obesityK Nanchahal, J N Morris, L M Sullivan, et al.
The American Journal of Medicine|May 5, 2009
Obesity: why be concerned?W Virgil Brown, Ken Fujioka, Peter W F Wilson, et al.
American Heart Journal|June 25, 2004
Concept and usefulness of cardiovascular risk profilesWilliam B Kannel, Ralph B D'Agostino, Lisa Sullivan, et al.
Annals of Internal Medicine|July 1, 1979
Uric acid excretion: quantitative assessment from spot, midmorning serum and urine samplesP A Simkin, P L Hoover, C S Paxson, et al.
Pageof 43

Showing results (61-70 of 424) with videos related to

Sort By:
Pageof 43
Clinical Chemistry|March 2, 2012
A message from the laboratory community to the National Cholesterol Education Program Adult Treatment Panel IVHubert W Vesper, Peter W F Wilson, Nader Rifai
The Australian and New Zealand Journal of Surgery|February 1, 1975
Pancreatic cyst complicated by major arterial erosion and gastrointestinal haemorrhageW F Wilson, R C Wilkie, M R Ewing
Circulation|June 11, 2008
Beyond established and novel risk factors: lifestyle risk factors for cardiovascular diseaseDariush Mozaffarian, Peter W F Wilson, William B Kannel
Circulation|June 16, 2004
Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?Paul M Ridker, Peter W F Wilson, Scott M Grundy
Metabolic Syndrome and Related Disorders|March 29, 2008
Cardiovascular risk and the metabolic syndromeMartin K Rutter, James B Meigs, Peter W F Wilson
Circulation|July 1, 1997
Intermittent claudication. A risk profile from The Framingham Heart StudyJ M Murabito, R B D'Agostino, H Silbershatz, et al.
International Journal of Obesity (2005)|December 15, 2004
Coronary heart disease risk in men and the epidemic of overweight and obesityK Nanchahal, J N Morris, L M Sullivan, et al.
The American Journal of Medicine|May 5, 2009
Obesity: why be concerned?W Virgil Brown, Ken Fujioka, Peter W F Wilson, et al.
American Heart Journal|June 25, 2004
Concept and usefulness of cardiovascular risk profilesWilliam B Kannel, Ralph B D'Agostino, Lisa Sullivan, et al.
Annals of Internal Medicine|July 1, 1979
Uric acid excretion: quantitative assessment from spot, midmorning serum and urine samplesP A Simkin, P L Hoover, C S Paxson, et al.
Pageof 43